期刊文献+

芳香乙酰胺类化合物的合成及其抑制幽门螺杆菌活性研究

Studies on the Synthesis and Anti-helicobacter Pylori Activity of Arylacetamide Derivatives
下载PDF
导出
摘要 设计并合成了10个N-(3-甲基氨基甲酰基苯基)-芳香乙酰胺类化合物和10个N-间溴苯基-芳香乙酰胺类化合物,并通过NMR、MS等确认它们的结构。幽门螺杆菌(Hp)体外抑制活性测试初步结果表明,化合物W2、W3、W4、W9和W10对Hp表现一定的抑制活性,其中W2的抗Hp活性最好。 Ten N-(3-methylcarbamoylphenyl)-arylacetamides and ten N-(3-bromophe nyl)-arylacetamides were synthesized,their structures were confirmed by NMR and MS individually.The preliminary results against Helicobacter pylori (Hp) indicated that compounds W2、W3、W4、W9 and W10 could show a significant antibacterial activity against Hp,and the compound W2 is the most potent one.
出处 《科学技术与工程》 北大核心 2014年第19期189-193,共5页 Science Technology and Engineering
基金 贵州省中药现代化专项[黔科合ZY(2011)3001] 贵阳市科技计划项目现代药业计划[筑科合同(20111204)1号]资助
关键词 芳香乙酰胺类化合物 合成 幽门螺杆菌 Arylacetamide derivatives Synthesis Helicobacter pylori
  • 相关文献

参考文献6

  • 1Warren J R, Marshall B J. Unidentified curved bacilli on gastric epi- thelium in active chronic gastritis. Lancet, 1983; 1 ( 8336 ) : 1273-1275.
  • 2Petersen A M, Krogfelt K A. Helicobacter pylori : an invading micro- organism? a review. FEMS Immun Med Microb, 2003; 36 ( 3 ) : 117-126.
  • 3Bazzoli F, Olivieri L, De Luca L, et al. Therapy and drug resistance in Helicobacter pylori infection. Digest Liver Dis, 2000 ; 32 ( 3 ) : S207-S210.
  • 4Malfertheiner P, Megraud F, 0' Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht lII Consensus Report. Gut,2007 ;56 (6) :772-781.
  • 5Ando R, Kawamura M, Chiba N. 3-(Arylac-etylamino)-N-methyl- benzamides : a novel class of selective anti-helicobacter pylori agents. J Med Chem,2001 ;44(25) : 4468-4474.
  • 6Ryoichi A, Kawamura M, Chiba N, et al. Preparation of acylamino- benzamides as antibacterials useful against Helicobacter pylori and/or Campylobacter jejuni. U. S. (2002) ,US 6444849 B1 20020903.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部